V. H. Prajapati, “Association Between Early Clinical Responses and Long-Term Outcomes With Ruxolitinib Cream Treatment in Mild to Moderate Atopic Dermatitis”, J of Skin, vol. 8, no. 2, p. s373, Mar. 2024.